An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

Clinical trial NCT06799611 · RECRUITING

Trial details

NCT number: NCT06799611
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)Treatment

Start date: 2025-03-03
Primary completion: 2026-01-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.